Qiagen reported a strong set of Q2 16 numbers, beating both the market’s expectations and its own guidance. NB all sales growth numbers at CER, unless specified otherwise. Net sales growth of 6% (vs company guidance: 4%) was a mix of 5% organic growth and a 1% contribution from the acquisition of Mo Bio Laboratories. Sequential moderation of currency headwinds meant that forex had just a 1% negative impact (vs. 2% negative impact in Q1 16), resulting in the reported net sales growth of
30 Sep 2016
Back on track
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Back on track
Qiagen reported a strong set of Q2 16 numbers, beating both the market’s expectations and its own guidance. NB all sales growth numbers at CER, unless specified otherwise. Net sales growth of 6% (vs company guidance: 4%) was a mix of 5% organic growth and a 1% contribution from the acquisition of Mo Bio Laboratories. Sequential moderation of currency headwinds meant that forex had just a 1% negative impact (vs. 2% negative impact in Q1 16), resulting in the reported net sales growth of